Sunscreen protection in the ultraviolet A region: How to measure the effectiveness

Photodermatology Photoimmunology and Photomedicine

Volumn 17, Issue 1, 2001, Pages 2-10

  Cole, C ^a  

^a Johnson and Johnson CPI ^*  (United States)

Author keywords

Absorbance; Critical walvelength; Efficacy; Measurement; Persistent pigment darkening; Photostability; Protection factor A; Sun protection factor; Sunscreens; Ultraviolet A

Indexed keywords

SUNSCREEN;

DRUG EFFICACY; HUMAN; PRIORITY JOURNAL; RADIATION ABSORPTION; RADIATION PROTECTION; RADIATION SCATTERING; REVIEW; SKIN PROTECTION; SOLAR RADIATION; SUNBURN; SUNLIGHT; ULTRAVIOLET A RADIATION; ULTRAVIOLET B RADIATION;

ANIMALS; CONSUMER PRODUCT SAFETY; HUMANS; MATERIALS TESTING; SKIN; SUNLIGHT; SUNSCREENING AGENTS; ULTRAVIOLET RAYS;

EID: 0035145239     PISSN: 09054383     EISSN: None     Source Type: Journal    
DOI: 10.1034/j.1600-0781.2001.017001002.x     Document Type: Review

References (53)

1. The contributions of UVA and UVB to connective tissue damage in hairless mice
2. An animal model of solar-aged skin: Histological, physical and visible changes in UV-irradiated mouse skin
3. An action spectrum for ultraviolet induced elastosis in hairless mice: Quantification of elastosis by image analysis
4. The carcinogenic effect of UVA irradiation
5. Carcinogenesis induced by UVA (365-nm) radiation: The dose-time dependence of tumor formation in hairless mice
6. Wavelength dependence of skin cancer induction by ultraviolet irradiation of albino hairless mice
7. A comparison of in vivo and in vitro testing of sunscreening formulas
8. A new substrate to measure sunscreen protection factors throughout the ultraviolet spectrum
9. A rapid in vitro model for UVB and UVA sunscreen testing
10. A method for determination of UVA protection for normal skin
11. A method for broad-spectrum classification of sunscreens
12. The effect of an ultraprotective sunscreen on Langerhans cell alteration induced by ultraviolet light in human skin
13. Broad spectrum sunscreens provide greater protection against ultraviolet radiation induced suppression of contact hypersensitivity to a recall antigen in humans
14. Measurement of in vivo sunscreen immune protection factors in humans
15. Assessment by mouse model of the ultraviolet A protective effect of topical sunscreens
16. Sunscreen protection against ultraviolet radiation-induced pyrimidine dimers in mouse epidermal DNA
17. Sunscreens prevent ultraviolet photocarcinogenesis
18. The contributions of UVA and UVB to connective tissue damage in hairless mice
19. The effects of UVA radiation: Are sunscreens protective enough?
20. Sunscreens promote repair of ultraviolet radiation induced dermal damage
21. An animal model of solar-aged skin: Histological, physical, and visible changes in UV irradiated hairless mouse skin
22. The nature of photoaging: Its prevention and repair
23. Cumulative effects from repeated exposures to suberythemal doses of UVB and UVA in human skin
24. A novel in vivo model for evaluating agents that protect against ultraviolet A-induced photoaging
25. Broad-spectrum sunscreens with UVAI and UVAII absorbers provide increased protection against solar-simulating radiation-induced dermal damage in hairless mice
26. The effects of chronic sunscreen use on the histologic changes of dermatoheliosis
27. Reduction of solar keratoses by regular sunscreen use
28. Epidermal changes in human skin following irradiation with either UVB or UVB
29. Efficacy of a sunscreen containing butyl methoxydibenzoylmethane against ultraviolet A radiation in photosensitized subjects
30. Indoor and outdoor efficacy testing of a broad-spectrum sunscreen against ultraviolet A radiation in psoralen-sensitized subjects
31. Comparison of methods for assessing photoprotection against ultraviolet A in vivo
32. Evaluating the UVA protection of sunscreens
33. Tumors of the skin in the HRA/Skh mouse after treatment with 8-methoxypsoralen and UVA radiation
34. Consensus workshop on the toxic effects of long-term PUVA therapy
35. Malignant melanoma in patients treated for psoriasis with PUVA
36. Ultraviolet A sunscreen evaluations in normal subjects
37. Measurement of sunscreen UVA protection: An unsensitized human model
38. Multicenter evaluation of sunscreen UVA protectiveness with the protection factor test method
39. Determination of UVA protection factors by means of immediate pigment darkening in normal skin
40. Immediate pigment darkening thresholds of human skin to monochromatic (362 nm) ultraviolet A radiation are fluence rate dependent
41. Measurement of sunscreen UVA protection: An unsensitized human model
42. Pigment darkening persistent effect, reciprocity law, doses and observation time. FDA: Public meeting to discuss UVA claims and testing procedures for OTC sunscreen drug products (Rockville, USA)
43. Cutaneous effects of pulsed nitrogen gas laser irradiation
44. Erythema and melanogenesis actin spectra of normal human skin
45. Persistent pigment darkening response for evaluation of ultraviolet A protection assays
46. Standard test methods for classification and labeling of sunscreen having UVA protection efficacy in Japan
47. Noninvasive in vivo determination of sunscreen ultraviolet A protection factors using diffuse reflectance spectroscopy
48. Mexoryl® SX protects against solar-simulated UVR-induced photocarcinogenesis in mice